Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.12 USD | -2.80% | +1.96% | -28.77% |
Apr. 17 | Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024 | CI |
Apr. 15 | Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.77% | 80.15M | |
+5.38% | 69.91B | |
+10.97% | 9.03B | |
-17.03% | 4.75B | |
+37.51% | 4.31B | |
+3.92% | 3.88B | |
+18.40% | 2.37B | |
-24.13% | 2.26B | |
-29.70% | 2.2B | |
+9.09% | 1.98B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- Eton Pharmaceuticals : B. Riley Lowers Eton Pharmaceuticals' PT to $11 from $13 on Lowered Probability of Success for DS100, Keeps Buy Rating